NCT01574170 2026-04-17
METAL3
Institut Claudius Regaud
Phase 4 Completed
Clinical Trials
13 trialsNCT01127295 2026-04-14
PHACS
Institut Claudius Regaud
Phase 4 Completed
NCT01553903 2026-04-14
OXYTAM
Institut Claudius Regaud
Phase 4 Completed
NCT01612871 2026-04-14
MIRHO
Institut Claudius Regaud
Phase 4 Completed
NCT07195344 2026-04-09
TDXdose
Institut Claudius Regaud
Phase 4 Recruiting
NCT07220967 2026-04-09
A Study of Antibiotic Delivery to Prevent Infection After Breast Tissue Expander Placement
Memorial Sloan Kettering Cancer Center
Phase 4 Recruiting
NCT04549207 2026-04-07
Comparing Continuation or De-escalation of Bone Modifying Agents (BMA) in Patients Treated for Over 2 Years for Bone Metastases From Either Breast or Castration-resistant Prostate Cancer
Ottawa Hospital Research Institute
Phase 4 Active not recruiting
NCT05365230 2026-04-07
A Randomized Trial Evaluating Personalized vs Guideline-based Well Follow-up Strategies for Patients With Early-stage Breast Cancer
Ottawa Hospital Research Institute
Phase 4 Completed
NCT06274515 2026-04-06
REMERGE
Hoffmann-La Roche
Phase 4 Recruiting
NCT05161195 2026-04-02
Roll-over Study to Allow Continued Access to Ribociclib
Novartis
Phase 4 Active not recruiting
NCT05754528 2026-04-02
REaCT-TEMPO
Ottawa Hospital Research Institute
Phase 4 Active not recruiting
NCT07490509 2026-04-01
DOSABEMA
Poitiers University Hospital
Phase 4 Not yet recruiting
NCT07487129 2026-03-23
Clinical and P
Beni-Suef University
Phase 4 Completed